Previous 10 | Next 10 |
Hamilton, Bermuda, April 24, 2024 (GLOBE NEWSWIRE) -- Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis published in Allergy journal Study met primary efficacy endpoint of improvement in nasal symptoms (p = 0.013) Corroborated ...
2024-04-10 11:18:10 ET Altamira Therapeutics Ltd. (CYTO) Q4 2023 Earnings Conference Call April 10, 2024, 08:30 AM ET Company Participants Thomas Meyer - Founder, Chairman & Chief Executive Officer Covadonga Pañeda - Chief Operating Officer Presentatio...
2024-04-10 08:04:14 ET More on Altamira Therapeutics Altamira stock rallies 44% on Univercells mRNA collaboration Altamira Therapeutics stock jumps 7% as it files for second patent Financial information for Altamira Therapeutics Read the full article on See...
Hamilton, Bermuda, April 10, 2024 (GLOBE NEWSWIRE) -- Management to host conference call today, April 10, at 8.30 a.m. EDT RNA delivery business progressing with new collaborations, potential new applications Partnering of legacy assets underway as Company transitions to f...
2024-04-09 09:33:28 ET Major earnings expected before the bell on Wednesday include: Applied Digital Corporation ( APLD ) Altamira Therapeutics Ltd. ( CYTO ) Delta Air Lines ( DAL ) For Seeking Alpha's full earnings season calendar, click here . Rea...
Hamilton, Bermuda, April 04, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA delivery to extrahepatic targets, today announced that it will host its Full Year 2023 Financial Resul...
A look at the top 10 most actives in the United States Next.e.GO N.V. (EGOX) rose 29.5% to $0.0509 on volume of 289,179,589 shares Nikola Corporation (NKLA) rose 12.3% to $0.7436 on volume of 164,247,182 shares KULR Technology Group Inc. (KULR) rose 55.6% to $0.3251 on volume of 123,355,3...
2024-03-25 12:19:30 ET More on Altamira Therapeutics Altamira Therapeutics stock jumps 7% as it files for second patent Financial information for Altamira Therapeutics Read the full article on Seeking Alpha For further details see: Altamira stock rallies ...
2024-03-25 10:00:59 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Johnson & Johnson, Boston Scientific least shorted stocks in S&...
A look at the top 10 most actives in the United States Next.e.GO N.V. (EGOX) rose 90.8% to $0.075 on volume of 125,000,352 shares Fisker Inc. Class A (FSR) fell 28.2% to $0.08965 on volume of 60,620,440 shares Lucid Group Inc. (LCID) rose 17.3% to $3.2489 on volume of 33,193,462 shares ...
News, Short Squeeze, Breakout and More Instantly...
Altamira Therapeutics Ltd. Company Name:
CYTO Stock Symbol:
NASDAQ Market:
Altamira Therapeutics Ltd. Website:
Hamilton, Bermuda, June 20, 2024 (GLOBE NEWSWIRE) -- Independent review discusses evidence supporting the use of betahistine to alleviate residual dizziness following physical repositioning procedures in benign paroxysmal positional vertigo (BPPV) patients Betahistine is markete...
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 37.1% to $0.108 on volume of 436,246,446 shares Ascent Solar Technologies Inc (ASTI) rose 114.8% to $0.282249 on volume of 221,176,942 shares OneMedNet Corp (ONMD) rose 134.7% to $1.15 o...
Hamilton, Bermuda, May 23, 2024 (GLOBE NEWSWIRE) -- HAMIL TON, BERMUDA – May 23, 2024 -- Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and commercializing RNA delivery technology for targets bey...